Semaglutide May Lower Burden of Hospitalizations in High-Risk Patients

FRIDAY, Jan. 2, 2026-- For patients at high cardiovascular risk with overweight or obesity, semaglutide is associated with reduced burden of total hospital admissions, according to a study published online Dec. 23 in JAMA Cardiology.Stephen J...